ArticleBMC cancer2022

Predictive value of baseline metabolic tumor volume in early-stage favorable Hodgkin Lymphoma - Data from the prospective, multicenter phase III HD16 trial.

Lutz van Heek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.